Asciminib After One Prior Tyrosine Kinase Inhibitor (TKI) in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP): A Real-World Chart Review Study in the United States (US)

被引：0

作者：

Atallah, Ehab L. ^{[1
]}

Sadek, Islam ^{[2
]}

Wei, David ^{[2
]}

Latremouille-Viau, Dominick ^{[3
]}

Rossi, Carmine ^{[3
]}

Damon, Andrea ^{[2
]}

Yang, Daisy ^{[2
]}

Bellefleur, Remi ^{[3
]}

Guerin, Annie ^{[3
]}

Jadhav, Kejal ^{[2
]}

机构：

[1] Med Coll Wisconsin, Milwaukee, WI USA

[2] Novartis Pharmaceut, E Hanover, NJ USA

[3] Anal Grp Inc, Montreal, PQ, Canada

来源：

关键词：

CML; asciminib; chronic myeloid leukemia; chronic phase; treatment patterns; real-world data;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CML-196

引用

页码：S365 / S365

页数：1